# Amgen to build $550M biotech manufacturing facility in Holly Springs, North Carolina

Amgen announced plans to invest $550 million to build a new manufacturing facility in Holly Springs, North Carolina, creating 355 jobs. The facility is set to begin operating in 2025.

- Type: New facility
- Announced: 2021-08-03
- Where: Holly Springs, North Carolina, United States
- Value: $550.0M
- Jobs: 355
- Starts operating: 2025
- Status: announced
- Products: biologic medications
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Amgen](https://endata.com/companies/21121.md)

## Sources

- [wake.gov](https://www.wake.gov/news/global-biotech-leader-amgen-chooses-holly-springs-new-manufacturing-facility), 2021-08-03: "We chose North Carolina for this new plant because of the robust biologics ecosystem, and we are excited to partner with the Wake County business community to further expand biotechnology regionally."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.